TransCode Therapeutics, Inc.
RNAZ
$6.97
-$0.235-3.26%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 99.09% | 209.78% | -44.08% | -31.73% | 77.54% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -38.36% | -35.34% | 439.65% | -69.02% | -42.18% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.19% | -22.14% | 29.30% | -37.07% | 30.13% |
| Total Current Assets | 83.90% | 96.35% | -17.64% | -34.67% | 50.69% |
|
|
|||||
| Total Current Assets | 83.90% | 96.35% | -17.64% | -34.67% | 50.69% |
| Net Property, Plant & Equipment | -57.33% | -57.82% | -35.12% | -29.77% | -22.88% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | 80.88% | 85.32% | -18.42% | -33.82% | 41.02% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | -7.33% | 27.05% | -34.92% | 38.38% | -22.43% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -74.89% | -32.88% | -33.06% | -17.68% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -9.46% | 21.36% | -34.79% | 29.42% | -22.47% |
|
|
|||||
| Total Current Liabilities | -9.46% | 21.36% | -34.79% | 29.42% | -22.47% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -94.01% | -- | -- | -- | -- |
| Total Liabilities | -68.84% | 307.78% | -34.79% | 29.42% | -23.31% |
|
|
|||||
| Common Stock & APIC | 39.87% | 3.86% | 4.71% | 3.55% | 13.05% |
| Retained Earnings | -19.12% | -10.39% | -4.23% | -10.44% | -7.17% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 609.87% | -222.18% | 24.95% | -71.16% | 179.39% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 609.87% | -222.18% | 24.95% | -71.16% | 179.39% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 609.87% | -222.18% | 24.95% | -71.16% | 179.39% |
|
|
|||||